Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Contracts + Grants

    DARPA Biotechnology EZ BAA Cuts the Red Tape

    By Global Biodefense StaffNovember 9, 2014
    DARPA Biological Technologies
    Credit: Shutterstock
    Share
    Facebook LinkedIn Reddit Email

    DARPA Biological Technologies Office (BTO)The Defense Advanced Research Projects Agency (DARPA) has simplified its Broad Agency Announcement (BAA) proposal process to better attract and fund new ideas in biotechnology.

    This new Biotechnology EZ BAA, overseen by DARPA’s Biological Technologies Office (BTO), provides the opportunity for innovators to receive seed funding of up to $700,000 simply by submitting an initial two-page white paper describing their ideas.

    “Some of the most exciting work in biotech is happening at the edges and intersections of disciplines, by people who in many cases have never worked with the government before and don’t know how to navigate traditional funding channels,” said Dr. Alicia Jackson, deputy director of DARPA’s Biological Technologies Office. “Since DARPA itself operates at the edges of science and technology, these are often precisely the people with whom we want to be in business. So we’ve created a process that they can relate to.”

    Unlike traditional BAAs, which specify topics and minimum performance requirements, the EZ BAA is open to any idea with the potential to yield revolutionary new capabilities in the biotech. This eliminates the need for proposers to search or wait for specific opportunities relevant to their expertise.

    BAAs also typically run 40 to 60 pages and requires highly structured responses from proposers. Under the simplified EZ BAA, DARPA managers will review the 2-page white papers within just a few weeks of submission, and either encourage or discourage submission of a full proposal of no more than 20 pages.

    The full proposals will be limited to a cover sheet, optional submission letter, 200-word layman’s summary, goals and impact statement, statement of work, management plan, description of organizational capabilities, and a cost summary; proposers must also submit a separate cost proposal detailing planned expenditures. DARPA will evaluate proposals based on scientific and technical merit, cost realism, and relevance and potential contribution to the DARPA mission.

    DARPA’s contract management team basically trimmed the standard BAA to remove everything but the bare essentials to get the funding process going, making the process less daunting to those unfamiliar with federal contracting requirements.

    Proposers can choose from two funding mechanisms in their submissions: “other transactions” or fixed-price procurement contracts. Other transactions are particularly suited to the development of dual-use technologies (those with both defense and commercial applications) or when participants are largely from commercial industry.

    Source: DARPA press release, adapted.

    BAA DARPA
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleBiodefense Headlines – November 9, 2014
    Next Article First of Six British Ebola Treatment Facilities Opens in Sierra Leone

    Related Stories

    New Method Improves Quantification of Ricin in Complex Matrices

    September 20, 2023

    Terrorism and the Pandemic: Weaponizing a Public Health Crisis

    September 20, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023

    Mass Spec for Rapid Detection of Biological Warfare Agents

    September 15, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    Oct 17
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Dispensing and Administration of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy